Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (78)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Seaton, M.J.
Right arrow Articles by Bond, J.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seaton, M.J.
Right arrow Articles by Bond, J.A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 Oxford University Press

other

Oxidation of 1,2-epoxy-3-butene to 1,2:3,4-diepoxybutane by cDNA-expressed human cytochromes P450 2E1 and 3A4 and human, mouse and rat liver microsomes

M.J. Seaton 1, M.H. Follansbee 2 and J.A. Bond 1 3

1Chemical Industry Institute of Toxicology, Research Triangle Park NC, USA
2Pennsylvania State University College of Medicine, Hershey PA, USA

3To whom correspondence should be addressed

1,3-Butadiene is carcinogenic in B6C3F1 mice and Sprague- Dawley rats, and has been classified as a probable human carcinogen. The genetic basis for butadiene carcinogenicity is likely mediated by its metabolite, 1,2:3,4-diepoxybutane (BDE). Oxidation of butadiene to 1,2-epoxy-3-butene (BMO) and further activation to BDE is catalysed by cytochrome P450 (CYP) isozymes. The production of BMO from butadiene is mediated by CYP2E1 and, at high butadiene concentrations, by CYP2A6. The purpose of the present study was to identify which human CYP isozymes have the ability to oxidize BMO to BDE, and to determine the extent to which this reaction occurs in B6C3F1 mouse, Sprague-Dawley rat, and human liver microsomes. Of the human cDNA-expressed CYP isozymes tested, only CYP2E1 formed detectable concentrations of BDE at 80 µ.M BMO. CYP2E1 and CYP3A4 were active at 5.0 mM BMO. Interindividual and interspecies variation in the Initial rate of oxidation of 80 µM BMO to BDE was determined using 10 samples of human liver microsomes and single pooled samples from rats and mice. Those experiments revealed a 60-fold variation in activity among 10 human liver samples (range: 0.005–0.324 nmol/mg protein/mm). Rates of BMO oxidation for mouse and rat liver microsomes were 0.473 and 0.166 nmol/mg protein/mm, respectively. Apparent kinetic constants for the oxidation of BMO to BDE by four human microsomal preparations, and pooled samples from mice and rats were estimated from detailed investigations of BMO oxidation at various BMO substrate concentrations. Apparent Km for the human liver samples ranged from 0.304–0.880 mM, and Vmax values ranged from 0.38 to 1.2 nmol/mg protein/mim The apparent values of Km and Vmax for mouse liver microsomes were 0.141±0.007 mM (mean±SE) and 1.303±0.141 nmol/mg protein/ min, respectively. For rat liver microsomes, apparent Km and V were 0.145±0.036 mM and 0.408±0.031 mnol/mg protein/mm, respectively. Measured rates of BDE formation correlated well with CYP2E1 protein concentrations in the human microsome samples. These results implicate human CYP2E1 as a hepatic isoform responsible for the oxidation of BMO to BDE at low concentrations of BMO. Moreover, our in vitro results reveal that microsomes prepared from human, rat and mouse liver possess the ability to form BDE from BMO. Previous in vitro results suggest that following exposure to butadiene more BMO would probably be present in mice than in rats or humans. Thus, in mice more BMO would be available for activation to BDE. This may explain in part the high sensitivity of this mouse strain to butadlene-induced cancer.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
S. Z. Abdel-Rahman, M. M. Ammenheuser, C. J. Omiecinski, J. K. Wickliffe, J. I. Rosenblatt, and J. B. Ward Jr.
Variability in Human Sensitivity to 1,3-Butadiene: Influence of Polymorphisms in the 5'-Flanking Region of the Microsomal Epoxide Hydrolase Gene (EPHX1)
Toxicol. Sci., May 1, 2005; 85(1): 624 - 631.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
G Pagano
Redox-modulated xenobiotic action and ROS formation: a mirror or a window?
Human and Experimental Toxicology, February 1, 2002; 21(2): 77 - 81.
[Abstract] [PDF]


Home page
CarcinogenesisHome page
M. Futaki, T. Igarashi, S. Watanabe, S. Kajigaya, A. Tatsuguchi, J. Wang, and J. M. Liu
The FANCG Fanconi anemia protein interacts with CYP2E1: possible role in protection against oxidative DNA damage
Carcinogenesis, January 1, 2002; 23(1): 67 - 72.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
G Pagano, P Degan, A De Biase, M Iaccarino, and M Warnau
Diepoxybutane and mitomycin C toxicity is associated with the induction of oxidative DNA damage in sea urchin embryos
Human and Experimental Toxicology, December 1, 2001; 20(12): 651 - 655.
[Abstract] [PDF]


Home page
Drug Metab. Dispos.Home page
R. A. Kemper, R. J. Krause, and A. A. Elfarra
Metabolism of Butadiene Monoxide by Freshly Isolated Hepatocytes from Mice and Rats: Different Partitioning between Oxidative, Hydrolytic, and Conjugation Pathways
Drug Metab. Dispos., June 1, 2001; 29(6): 830 - 836.
[Abstract] [Full Text]


Home page
Toxicol SciHome page
T. E. Jackson, P. D. Lilly, L. Recio, P. M. Schlosser, and M. A. Medinsky
Inhibition of Cytochrome P450 2E1 Decreases, but Does Not Eliminate, Genotoxicity Mediated by 1,3-Butadiene
Toxicol. Sci., June 1, 2000; 55(2): 266 - 273.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. G. Korkina, I. B. Deeva, A. De Biase, M. Iaccarino, R. Oral, M. Warnau, and G. Pagano
Redox-dependent toxicity of diepoxybutane and mitomycin C in sea urchin embryogenesis
Carcinogenesis, February 1, 2000; 21(2): 213 - 220.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
M.n. Murg, M. Schuler, and D.A. Eastmond
Evaluation of micronuclei and chromosomal breakage in the 1cen-q12 region by the butadiene metabolites epoxybutene and diepoxybutane in cultured human lymphocytes
Mutagenesis, November 1, 1999; 14(6): 541 - 546.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
J. K. Doerr-Stevens, J. Liu, G. J. Stevens, J. C. Kraner, S. M. Fontaine, J. R. Halpert, and I. G. Sipes
Induction of Cytochrome P-450 Enzymes after Repeated Exposure to 4-Vinylcyclohexene in B6C3F1 Mice
Drug Metab. Dispos., February 1, 1999; 27(2): 281 - 287.
[Abstract] [Full Text]


Home page
BloodHome page
F. A.E. Kruyt, T. Hoshino, J. M. Liu, P. Joseph, A. K. Jaiswal, and H. Youssoufian
Abnormal Microsomal Detoxification Implicated in Fanconi Anemia Group C by Interaction of the FAC Protein With NADPH Cytochrome P450 Reductase
Blood, November 1, 1998; 92(9): 3050 - 3056.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
R. A. Kemper, A. A. Elfarra, and S. R. Myers
Metabolism of 3-Butene-1,2-diol in B6C3F1 Mice. Evidence for Involvement of Alcohol Dehydrogenase and Cytochrome P450
Drug Metab. Dispos., September 1, 1998; 26(9): 914 - 920.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.